Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,521
Closed -$266K 507
2026
Q1
$266K Buy
3,521
+1
+0% +$75 0.03% 226
2025
Q4
$262K Sell
3,520
-8
-0.2% -$585 0.03% 229
2025
Q3
$238K Sell
3,528
-50
-1% -$3.32K 0.03% 297
2025
Q2
$233K Buy
+3,578
New +$214K 0.03% 310
2025
Q1
Sell
-2,778
Closed -$200K 322
2024
Q4
$200K Buy
2,778
+54
+2% +$4.22K 0.03% 295
2024
Q3
$222K Buy
2,724
+14
+0.5% +$1.12K 0.04% 246
2024
Q2
$201K Buy
+2,710
New +$203K 0.04% 217

Other funds holding HOLX

Claret Asset Management's HOLX Position: Q2 2026 in Review

Claret Asset Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,521 shares — an estimated $266K sold.

Claret Asset Management first reported a position in HOLX in Q2 2024 and held it in 7 quarters. The position peaked at $266K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Claret Asset Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Claret Asset Management sold 3,521 Hologic shares in Q2 2026, an estimated $266K.
  • Claret Asset Management first reported a position in Hologic in Q2 2024 and held it in 7 quarters.
  • Claret Asset Management's Hologic position peaked at $266K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.